A Genetic Study for Alzheimer Dementia: Case-control Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-26

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find out the difference in genetic test results between Alzheimer's dementia patients and healthy subjects.

The investigators want to identify genes that are importantly related to Alzheimer's dementia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Genetic Characterization of Dementia

NCT01867359

Dementia

COMPLETED

Alzheimer's Disease Genetics Study

NCT00064870

Alzheimer Disease Late Onset Alzheimer Disease Dementia

RECRUITING

Genetic Studies of Early-onset Dementia

NCT04906863

Dementia, Early Onset

RECRUITING

Genetic Studies in Familial Dementia

NCT04680013

Dementia of Alzheimer Type Alzheimer Disease, Late Onset Alzheimer Disease, Early Onset +2 more

COMPLETED

A Study to Compare Genetic Variations of IGF-I and IGF-II

NCT01329523

Dementia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Dementia (AD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Alzheimer's dementia patient and healthy subjects

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients over 60 years old
* Patients with a Alzheimer's dementia patient
* Total Korean version of mini-mental state examination (K-MMSE) score less than 24
* Total Clinical Dementia Rating (CDR) over 0.5

* Adult healthy over 60 years old
* Total Korean version of mini-mental state examination (K-MMSE) over 24
* Total Clinical Dementia Rating (CDR) is 0

Exclusion Criteria

* Those with severe medical conditions such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc., who are in poor general condition
* In the case of a person with impaired consent (MMSE less than 10 points), if not accompanied by a guardian
* Other cases where the researcher determines that participation in this clinical trial is not appropriate (Patients who are participating in other studies or have participated in other studies within the past 30 days can also participate in this study.)

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes